## **OVACOME** **Registered Charity No. 1159682** **REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 September 2024** Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Legal and Administrative Information** **_________________________________________________________________________________________________________** **Registered Charity Number:** 1159682 ## **Trustees (Executive Committee Members)** The trustees who served during the period and up to the date of signing of this report were: Cathryn Hughes (Chair) John Paul McKew (Treasurer) Marta Wojcik Sean Kehoe (Head of Expert Advisory Panel) Victoria Von Wachter Lesley Sage Adrian Dickinson Samixa Bakul Shah Richard Riley Michelle Hill ## **CEO** Victoria Clare ## **Patrons** Jenny Agutter Lady Adele Swell, M.B.E ## **Principal Office** 52-54 Featherstone Street London EC1Y 8RT ## **Independent Examiner** Kevin Fisher BA FCA CTA Kingston Burrows Audit Ltd 308 Ewell Road Surbitton Surrey, KT6 7AL ## **Bankers** CAF Bank Limited 25 Kings Hill Avenue Kings Hill West Malling Kent ME19 4JQ _____________________________________________________________________________ 2 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Trustees Report For the year ended 30 September 2024** **_________________________________________________________________________________________________________** The trustees are pleased to present their report together with the financial statements of the charity for the year ended 30 September 2024. Legal and administrative information set out on page 2 forms part of this report. The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the accounts and comply with the charity’s trust deed, the Charities Act 2011 and Statement of Recommended Practice: Accounting and Reporting Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and the Republic of Ireland (FRS102), issued in October 2019. ## **STRUCTURE, GOVERNANCE AND MANAGEMENT** ## **Legal structure of the charity** The charity is constituted as a charitable incorporated organisation (CIO). Ovacome was entered on the Register of Charities No 1159682 on 18 December 2014 and is governed by its constitution adopted also on 18 December 2014. Ovacome was originally established in 1996 as a charity on the Register of Charities and a ltd company at Companies House. It was then converted to a CIO in 2014. Ovacome has a board of 10 volunteer trustees, including individuals who have been personally affected by the disease and clinicians who specialise in ovarian cancer (OC). ## **Recruitment and induction of trustees** The trustees are appointed by the members or the charity trustees and are recruited for their knowledge, skills and experience. Ovacome is unique within the gynaecology oncology sector as the board includes a majority of trustees whose lives have been directly affected by ovarian cancer. In addition, Ovacome was established as a membership charity. Whilst anyone can access our support without being a member, it is free to become a member and members have certain rights and benefits conferred upon them. Members can vote at the Annual General Meeting (AGM) and they have the opportunity to participate in consultation to set the priorities of the charity and inform future strategic direction of service provision. Trustees are recruited following an annual trustee board skills audit. Areas for development are identified and then recruitment adverts are circulated among our membership and more widely. Trustees are recruited because of their skills and/or personal experience. All new trustees are given background information about the charity, are advised about their responsibilities and given an induction into the work of the charity. The training needs of the trustees are reviewed and training is sourced where deemed necessary and appropriate. The full recruitment process takes between 3-6 months. ## **Management and administration** The Executive Committee, members of which constitute trustees for the purpose of Charity legislation, administers Ovacome. The Chair, officers and other trustees are appointed (or reappointed) at the AGM. The Executive Committee reviews the profile of trustees periodically and appropriate appointments are made to ensure a balanced committee. No external bodies have the power to appoint trustees and the Executive Committee is ultimately responsible for the charity. The names of trustees who have served since 1 October 2023 are set out under Legal and Administrative Information on page 2 of this document. _____________________________________________________________________________ 3 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Trustees Report For the year ended 30 September 2024** **_________________________________________________________________________________________________________** The trustees meet via online conference calls monthly to review progress and support development of the charity in line with our organisational aims. The Chief Executive and staff team manage the day to day running of Ovacome and operational delivery based on the strategic direction agreed by the trustees. ## **Remuneration of Key Management Personnel** The remuneration of the charity’s key management personnel is set by the Executive Committee, taking into account the charity’s financial position and the amount paid for compatible roles in comparable organisations. ## **OBJECTIVES AND ACTIVITIES** Currently our head office is in London. Ovacome also has an office base in Dudley with a partner charity. As of 30 September 2024 there are 17 staff (12 full time, 5 part time). Ovacome has 98 registered and active volunteers at the time of writing. ## **The charity serves:** - People who have been diagnosed with ovarian cancer - Family members of those diagnosed - Those who may be at risk of OC - The general public (by raising awareness of the symptoms) - The research community by funding opportunities for better understanding and curing ovarian cancer - Clinicians specialising in ovarian cancer - Health care providers who may be involved in identifying and treating ovarian cancer The number of ovarian cancer cases in the UK is not thought to be increasing significantly. Around 7,500 new cases are diagnosed each year and this number has remained constant for some time. 1 in 50 women born after 1960 are diagnosed with ovarian cancer in their lifetime. But still: There is little awareness of the signs and symptoms of the disease among the public and no effective screening tool. This means that most people are diagnosed at the later stages of the disease. The need for Ovacome remains constant. Until all people are aware of the symptoms and able to access equitable treatment, support and information Ovacome will continue to work to meet the needs of all those affected by the disease. Ovacome works across the UK via our support and information services, and we provide face to face support and work with local charities to improve the support available to all affected by ovarian cancer - regardless of where they live. Our potential reach. One study suggested that in 2010, 41,000 women were living with ovarian cancer in the UK. They will vary hugely in health, stages of the disease and their support needs. In more recent years we have seen significant advances in treatment options and trials access in the UK. If we assume that there are now more women living with the disease than in 2010 and accept that it is our role to support women with ovarian cancer, their family members, the clinicians that treat them, or those at risk of the disease, then our potential reach is substantially wider than the numbers currently accessing our services. Since 2018 we have worked actively with partner organisations and our members to become more representative of the UK population, with a diverse and supportive community. We have made all our services more accessible and inclusive and will continue to work to do so. We have actively challenged and changed policy to reduce the inequalities that many face when accessing diagnosis, treatment or support. _____________________________________________________________________________ 4 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Trustees Report For the year ended 30 September 2024** **_________________________________________________________________________________________________________** ## **Charity activities** Ovacome has provided a wide range of expert services free to all those affected by ovarian cancer since 1996. ## **We do this by:** ## **Supporting those affected by ovarian cancer with a friendly community** - Providing opportunities for those affected by ovarian cancer to meet and share their experiences - Do this both face-to-face and online; via support groups (including local hybrid groups); online workshops; online discussion forum; hybrid members day and health and wellbeing events ## **Raising awareness of ovarian cancer and its symptoms** - Promoting an understanding of the signs and symptoms of ovarian cancer and the patient experience, including targeted messaging to underserved groups who are overlooked in mainstream awareness campaigns - Campaigning to raise awareness of signs and symptoms using our research based B.E.A.T. campaign which supports early diagnosis - Educating clinicians in the symptoms and impact of ovarian cancer - Remaining at the forefront of knowledge and innovation in the diagnosis, treatment and communication in all matters related to ovarian cancer - Working with community groups and other organisations to undertake targeted campaigns in a wide range of formats and languages to ensure that those who face barriers to accessing diagnosis are more aware of the symptoms of the disease. ## **Informing and educating people about the disease** - Providing evidence-based, up to date information through our website, magazine, information booklets and across support service platforms - Building our community networks across the UK to ensure this information is reaching all who need it - Providing information as requested by our members in a variety of formats and languages, as required - Working with our world class board of expert advisors to ensure that factually accurate and up to date information is provided in a way that people can understand - Ensuring empathy, sensitivity and discretion in every stakeholder interaction we have ## **Influencing and advocating** - Advocating for prevention strategies, research and equity of treatment, experience, and outcomes for all those diagnosed with ovarian cancer - Identify and lead change to address the health inequalities in access to support for all - Collaborating with other organisations to ensure the voices of the people that we represent are considered by decision-makers - Fund research, including patient perspective research, as appropriate - Providing training and information sessions for clinicians on the symptoms of the disease _____________________________________________________________________________ 5 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Trustees Report For the year ended 30 September 2024** **_________________________________________________________________________________________________________** - and also on the patient experience - Ensuring that, wherever possible, patient voice is incorporated into decision making at a national and local level ## **Constantly monitoring our success in achieving our aims** - Regularly seek the views of our membership and the wider community to provide feedback on our actions and the impact they are having - Regularly review our actions against those providing similar services or partnership organisations ## **ACHIEVEMENT AND PERFORMANCE** ## **Review of the year** We continue to see steady demand for our support services across all our support channels. We provided direct support to 4,344 people through our support line, events, and support groups. Our qualified and experienced support staff provide up-to-date information regarding various areas of OC, including treatments and trials, risk, living with the disease, and symptom management, whilst also providing much needed emotional support. The community we support varies, from those recently diagnosed, to family and friends concerned about loved ones, people needing information about their familial risk of being diagnosed with the disease, to those going through treatment, a recurrence, or end of life planning. Our team are available every step of the way, and we are a lifeline for thousands. Our popular online forum remained busy, running 24 hours a day, 7 days a year and with membership reaching over 18,153 members by the end of the financial year. During the year we were able to scale up our face to face events, providing support events in the following towns and cities: - London - Liverpool - Birmingham - Newcastle - Inverness - Glasgow Our team work closely with our community and listen to their needs – as a result we continued to provide regular weekly online community sessions, through which people are able to relax and participate in an activity (such as crafts, yoga or exercise) with others who have been diagnosed with the disease. This provides invaluable community building opportunities and reduces loneliness, anxiety and isolation for many. A further series of webinars and workshops ran throughout the year, given by experts in their own field of work and particularly by members of our expert advisory panel. We are grateful to all those who have given their time and expertise over the course of the year to support our community. The topics for these clinical and medical updates are requested by members of our community and the attendees have the opportunities to ask questions of experts. Many of these talks and presentations are recorded and shared on our YouTube channel, this is helpful to many thousands of people and we are seeing an increasing number of healthcare providers sharing these webinar resources with their patients or using them as training tools for healthcare professionals. Over the course of the year our YouTube videos were watched over 34,000 times with over 2,600 hours of viewing. _____________________________________________________________________________ 6 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Trustees Report For the year ended 30 September 2024** **_________________________________________________________________________________________________________** At the request of our membership we have continued to run the following expert support groups over the course of the year: - Stoma group. A friendly space for anyone living with a colostomy, ileostomy or urostomy to chat with others in similar circumstances - End of life matters. A safe space to come together and discuss any issues around the end of life, from practical concerns, to talking to friends & family, to feelings around your own death and dying - Under 45s group for those diagnosed under the age of 45 - Rare cancers group for those diagnosed with an ovarian cancer that is not high grade serous - Friends and family group for family members and carers of those diagnosed with the disease - Bereavement group for anyone who has experienced the death of someone close to them due to ovarian cancer We continued to run local support groups and to support other gynecology oncology groups already in existence with grants, facilitation and information or specialist speakers. We have also produced a resource for anyone setting up an independent ovarian cancer support group and can provide information, grants, support and speakers to those committed to providing support at a local level. Our work has continued within Ovacome to reduce barriers to accessing our services and to improve inclusivity. This has led to our community becoming more diverse. We continue our work to ensure that all members of our community are supported to access diagnoses, treatment and support in a culturally appropriate and accessible way. Our community language support lines in Cantonese, Mandarin, Polish, Urdu, Bengali, Arabic, Punjabi and Gujarati have continued to meet demand and, as requested, we provide talks and support sessions or translated information in these and other languages. Over 800,000 people who face health inequalities were given targeted information about the signs and symptoms of the disease. Over 100 community groups and charities across the UK partnered with us to reach those facing barriers to accessing diagnosis, treatment and support. ## **Information provision and awareness raising** During the financial year, we grew our Expert Advisory Panel of professional volunteers, which now numbers 37. This panel is made up of top clinicians and experts in the field with a variety of specialities, they continue to give the charity access to expert advice and influence. We remain particularly grateful to the professionals, who give their time voluntarily. We have further expanded our information and fact sheet offer over the course of the year to continue to meet the requests of our members expressed through our consultation. We now offer 50 information booklets. These resources are reviewed regularly when information or evidence base changes and at least once every two years. Included within this offering is a suite of ‘Easy Read’ booklets, designed to give information to people with a Learning Disability or low levels of health literacy. Our Patient Experience in Practice (PEP) training sessions deliver valuable information in an impactful and personalised way and focus on the lived experience of those diagnosed with the _____________________________________________________________________________ 7 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Trustees Report For the year ended 30 September 2024** **_________________________________________________________________________________________________________** disease. These sessions are subdivided into: - STS sessions – Survivors Teaching Students. This trains medical students to recognise the signs and symptoms of ovarian cancer using the lived experience of those diagnosed with the disease. - EPE sessions - Enhancing Patient Experience. Through which we provide specific information to medical oncologists, surgeons and specialist nurses – all involved in treating those with ovarian cancer. These training sessions provide specialist information on the lived experience of those affected by ovarian cancer and facing barriers to diagnosis, treatment and support. Through the two programmes 2,689 healthcare professionals were trained to better recognise the symptoms of ovarian cancer and given help to improve experience for their patients. ## **FUNDRAISING** A huge thank you to all the amazing people that have supported our work through their donations and their fundraising, their support is the reason we are able to continue providing life changing support and vital information to those affected by ovarian cancer. Every year we have amazing supporters who take on the London Marathon, this year we had 18 people running for our work and together they raised £47,685. During the year one group called Friends of Frances raised £13,284 through swimming 800km between them in February, walking and running a collective 1,133km in seven days during March and finally hiking the length of Hadrian’s Wall in May. Janet Kerr and her family raised £6,019 at Ford Ride London. After being diagnosed with advanced ovarian cancer last autumn, Janet was determined to raise awareness of the disease’s signs and symptoms in the saddle, “I managed 7 miles, but they were the best 7 miles I have ever cycled!” reflects Janet. “John kept me company, but the others cycled 100 miles, which was fantastic!”. Phil Soderberg & friends took on yet another major challenge raising £50,000 through Chase the Sun cycling from the west coast to the east coast of Italy in memory of Debbie Baldwin. We also saw the 3rd annual Debbie Baldwin Gala return with friends and family coming together, they raised £21,599. In September the wonderful Touch of Teal event took place at the May Fair hotel raising £14,705. Apricot Clothing continued to support our work during ovarian cancer awareness month and they also donated £10,000 to support our Big Give campaign. The monumental efforts made by our community are humbling and we are so grateful for the funds they raise and the creativity and determination that they display in supporting our work. We would like to thank all our amazing supporters for their kindness and generosity; those who take on such incredible challenges across the UK and those that organise wonderful events and those that bake, sew and knit items to sell and raise funds for our services. _____________________________________________________________________________ 8 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Trustees Report For the year ended 30 September 2024** **_________________________________________________________________________________________________________** ## **FINANCIAL REVIEW** Gross income and expenditure figures for the year ended 30 September 2024 were income of £744,841 (2023 - £938,381) and expenditure of £955,718 (2023 - £899,140), giving an overall deficit of £210,877 (2023 - surplus £39,241). Restricted Funds of £249,405 were received during the year, of which £278,913 (including £85,648 unspent funds brought forward this year) were expended, leaving a deficit of £29,508 and cumulative £56,140 carry forward into 2024/25. As regards Designated Funds, the remaining Designated Funds relate to the Research Fund at the University of Birmingham . ## **Reserve policy** It is the trustees' aim to hold total reserves equating to a period of total expenditure of minimum three months in order to ensure continued financial security and to provide for contingencies. Ovacome holds certain funds in designated and restricted funds for designated projects. Ovacome maintains relationships with beneficiaries, in some cases, for many years. To this end it is important that Ovacome maintains a healthy balance of reserves. On 30 September 2024 the balance of total Funds stood at £488,154. Total expenditure in 2023-24 amounted to £955,718 so the balance at the year-end meets the three month reserves policy. The trustees have considered the current level of reserves and determined that this level is appropriate. ## **Risk management** The trustees actively review the major risks which the charity faces on a regular basis by maintaining an up to date risk register report. The risk register is regularly presented to the trustees and they input within their areas of specialism. The trustees believe that maintaining reserves at adequate levels, combined with an annual review of the controls over key financial systems will provide sufficient resources in the event of adverse conditions. The Trustees have also examined other operational and business risks faced by the charity and believe that the systems in place to mitigate significant risks offer the trust adequate protection. ## **Going concern** The trustees believe that by maintaining reserves at the levels required by the reserves policy and by regularly reviewing the charity’s key financial systems, they can ensure that sufficient resources are in place to mitigate significant risks. In the light of Covid-19, the trustees have examined the operational and business risks faced by the charity and believe that the systems and reserves in place offer the charity adequate protection and ensure its continuance as a going concern. ## **Public benefit** Ovacome has referred to the Charity Commission's general guidance on public benefit, including the guidance 'public benefit: running a charity (PB2),' when reviewing its aims and objectives and in planning future activities. In particular, the trustees consider how all activities contribute to its aims and objectives and believe that a clear benefit to the public is demonstrated. This is described in more detail throughout the Review of the Period. ## **PLAN FOR FUTURE PERIODS** Ovacome will continue our work to meet the needs of anyone affected by ovarian cancer in the UK. Our plans are outlined in our strategy, we will continue to deliver the services and projects as listed within our report above. _____________________________________________________________________________ 9 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Trustees Report For the year ended 30 September 2024** **_________________________________________________________________________________________________________** ## **STATEMENT OF EXECUTIVE COMMITTEE'S RESPONSIBILITIES** The trustees are responsible for preparing the trustees' report and the Financial Statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). The law applicable to charities in England & Wales requires the trustees to prepare Financial Statements for each financial year which give a true and fair view of the state of affairs of the charity and of its income and expenditure for that period. In preparing these Financial Statements, the trustees are required to: - select suitable accounting policies and then apply them consistently - observe the methods and principles of the Charities SORP 2019 (FRS 102) - make judgements and estimates that are reasonable and prudent - prepare the Financial Statements on the going concern basis unless it is inappropriate to presume that the charity will continue in operation The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the Financial Statements comply with the Charities Act 2011 and the Charity (Accounts and Reports) Regulations. They are also responsible for safeguarding the assets of the charity and hence taking reasonable steps for the prevention and detection of fraud and other irregularities. Approved by the Executive Committee and authorised for issue on 23 April 2025 and signed on its behalf by: Cathryn Hughes Trustee and Chair _____________________________________________________________________________ 10 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Independent Examiner's Report to the Trustees of Ovacome** **___________________________________________________________________________________________________________________________________ ____________** I report to the Charity trustees on my examination of the accounts of Ovacome for the year ended 30 September 2024, which are set out on page 12 to 24. ## **Responsibilities and basis of report** As the charity’s trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’). I report in respect of my examination of the charity’s accounts carried out under section 145 of the Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. ## **Independent examiner’s statement** Since the charity’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the Act. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies. I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 1. accounting records were not kept in respect of the Charity as required by section 130 of the Act; or 2. the accounts do not accord with those records; or 3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. Kevin Fisher BA FCA CTA (Senior Statutory Auditor) For and on behalf of Kingston Burrows Audit Ltd Statutory Auditors 308 Ewell Road Surbitton Surrey, KT6 7AL Date: 28 April 2025 _____________________________________________________________________________ 11 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c ## **OVACOME Statement of Financial Activities For the year ended 30 September 2024** |**____________________________________________**
**Notes**
**INCOME**
Donations and legacies
2
Charitable activities -
Fundraising
3
Investment income
**Total Income**
**EXPENDITURE**
Fundraising expenditure
4
Charitable activities
5
**Total Expenditure**
**Net income/(expenditure) for**
**the year before gains/(losses)**
**Transfer between funds**
**Net Movement in Funds**
**Reconciliation of funds:**
Funds brought forward
**Funds carried forward**|**_____________________________________________________________**
**Unrestricted**
**Funds**
**Restricted**
**Funds**
**Total Funds**
**2024**
**Total Funds**
**2023**
**£**
**£**
**£**
**£**
236,496
216,302
452,798
593,675
248,549
33,103
281,652
337,302
10,391
-
10,391
7,404| |---|---| ||**495,436**
**249,405**
**744,841**
**938,381**| ||151,698
-
151,698
176,749
525,107
278,913
804,020
722,391| ||**676,805**
**278,913**
**955,718**
**899,140**| ||(181,369)
(29,508)
(210,877)
39,241
-
-
-
-| ||(181,369)
(29,508)
(210,877)
39,241
613,383
85,648
699,031
659,790| ||**432,014**
**56,140**
**488,154**
**699,031**| _____________________________________________________________________________ 12 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Statement of Financial Activities For the year ended 30 September 2024** **_________________________________________________________________________________________________________** ## **Analysis of prior year total fund;** |**Notes**
**INCOME and ENDOWMENT**
Donations and legacies
2
Charitable activities -
Fundraising
3
Investment income
**Total Income**
**EXPENDITURE**
Fundraising expenditure
Charitable activities
4
**Total Expenditure**
**Net income/(expenditure) for**
**the year before gains/(losses)**
**Transfer between funds**
**Net Movement in Funds**
**Reconciliation of funds:**
Funds brought forward
**Funds carried forward**|**Unrestricted**
**Funds**
**Restricted**
**Funds**
**Total Funds**
**2023**
**Total Funds**
**2022**
**£**
**£**
**£**
**£**
422,714
170,961
593,675
547,891
301,908
35,394
337,302
266,171
7,404
-
7,404
1,710| |---|---| ||**732,026**
**206,355**
**938,381**
**815,772**| ||176,749
-
176,749
147,559
523,790
198,601
722,391
671,465| ||**700,539**
**198,601**
**899,140**
**819,024**| ||31,487
7,754
39,241
(3,252)
(975)
975
-
-| ||30,512
8,729
39,241
(3,252)
582,871
76,919
659,790
663,042| ||| ||**613,383**
**85,648**
**699,031**
**659,790**| _____________________________________________________________________________ 13 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Balance Sheet As at 30 September 2024** **_________________________________________________________________________________________________________** |**Notes**
**FIXED ASSETS**
Tangible fxed assets
7
**CURRENT ASSETS**
Stock
Debtors
8
Cash at bank and in hand:
CREDITORS: amounts falling due in one
year
9
**NET CURRENT ASSETS**
**NET ASSETS TOTALS**
**THE FUNDS OF THE CHARITY**
**INCOME FUNDS**
10
Restricted funds
Unrestricted funds:
General fund
Designated funds|**2024**
**£**
**£**
4,522
4,522
9,739
11,179
586,230
607,148
(123,516)
483,632
**488,154**
56,140
395,249
36,765
432,014
**488,154**|**2023**
**£**
**£**
4,837
4,837
12,465
11,179
708,563
732,207
(38,013)
694,194
**699,031**
85,648
576,618
36,765
613,383
**699,031**|**2023**
**£**
**£**
4,837
4,837
12,465
11,179
708,563
732,207
(38,013)
694,194
**699,031**
85,648
576,618
36,765
613,383
**699,031**| |---|---|---|---| ||||| ||||**699,031**| Approved by the Executive Committee and authorized for issue on 23 April 2025 and signed on its behalf by: John Paul McKew Treasurer and Trustee _____________________________________________________________________________ 14 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Statement of Cash Flows for the year ended 30 September 2024** **_________________________________________________________________________________________________________** |**Notes**
**Cash fow from operating activities**
Net cash provided by operating activities
**A**
**Cash fow from investing activities**
Investment income
Purchase of fxed assets
**Net cash provided by investing activities**
**Change in cash and cash equivalents in the year**
**Cash and cash equivalents at 1 Oct 2023**
**Cash and cash equivalents at 30th Sep 2024**
**B**
**Notes to the cash fow statement**
**A – reconciliation of net movement in funds to net cash**
**fow from operating activities**
**Net income/(expenditure) for the year (before investment**
**gains & losses)**
Depreciation charge
Investment Income
Decrease/(increase) in stock
Decrease/(increase) in debtors
(Decrease)/increase in creditors
**Net cash provided by operating activities**
**B – Analysis of cash and cash equivalents**
Cash at bank and in hand
- Closing balance of Cash in hand and Bank
**Total cash and cash equivalents**|**2024**
**£**
**(131,571)**
10,391
(1,153)
**9,238**
**(122,333)**
708,563
**586,230**
**2024**
**£**
(210,877)
1,468
(10,391)
2,726
-
85,503
**(131,571)**
586,230
**586,230**|**2023**
**£**
**10,014**
7,404
(2,582)| |---|---|---| |||**4,822**
**14,836**
693,727| |||**708,563**| |||**2023**
**£**
39,241
1,836
(7,404)
(4,176)
14,542
(34,025)| |||**10,014**| |||708,563
**708,563**| The notes on page 16 to 24 form part of these financial statements _____________________________________________________________________________ 15 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME** ## **Notes to the accounts for the year ended 30 September 2024** **_________________________________________________________________________________________________________** ## **1 Accounting Policies** ## **Basis of preparation** The financial statements have been prepared on a going concern basis under the historical cost convention. The financial statements have been prepared in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). The Charity is a public benefit entity for the purposes of FRS 102 and therefore the Charity also prepares its financial statements in accordance with the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (The FRS 102 Charities SORP) issued in October 2019 and the Charities Act 2011. The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest pound. ## **Going concern** The trustees have assessed whether the use of the going concern basis is appropriate and have considered possible events or conditions that might cast significant doubt on the ability of the charity to continue as a going concern. The trustees have made this assessment for a period of at least one year from the date of approval of the financial statements. In particular the trustees have considered the charity's forecasts and projections and have taken account of pressures on donation and event income. After making enquiries the trustees have concluded that there is a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. The charity therefore continues to adopt the going concern basis in preparing its financial statements. ## **Income Recognition** All income is recognised when there is entitlement to the funds, the receipt is probable and the amount can be measured reliably. Income is recognised in the year to which it relates and on an accruals basis. Legacies are included when the legacy is received or when the charity is notified of an impending distribution which can be quantified and receipt is probable, whichever is the earlier. Recoverable taxation is accounted for on an accruals basis. ## **Expenditure** Expenditure is accounted for on an accruals basis allocated directly to the expenditure headings as far as practically possible to reflect the activities of the charity. Charitable activities comprise direct expenditure including direct staff costs attributable to the activity. ## **Employee benefits** ## **i. Short term benefits** Short term benefits, including holiday pay and other similar non-monetary benefits, are recognised as an expense in the period in which the service is received. ## **ii. Pensions** Ovacome operates a defined contribution plan for its employees. These contributions are recognised as an expense when they are due. Amounts not paid are shown in accruals in the balance sheet. ## **Fund Accounting** Restricted funds are funds which are to be used in accordance with specific restrictions imposed by the donor or are raised by the charity for specific restricted purposes. _____________________________________________________________________________ 16 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Notes to the accounts for the year ended 30 September 2024** **_________________________________________________________________________________________________________** Unrestricted funds are funds which are available for use at the discretion of the trustees in furtherance of the general objects of the charity. Designated funds are funds which are available for use at the discretion of the trustees but have been earmarked by them for a specific purpose. ## **Fixed Assets and Depreciation** All assets costing more than £1,000 are capitalised. Depreciation on fixed assets is provided at rates estimated to write off the cost, less estimated residual value, of each asset over its expected useful economic life as follows: Computer Equipment and Mascot Costume 3 years (straight line basis) ## **Stock** Stocks of Ovacome fundraising merchandise are stated at the lower of cost and net realisable value. ## **Debtors and Creditors** Debtors and Creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairments are recognised in expenditure. ## **Cash and cash equivalents** Cash and cash equivalents include cash in hand, deposits held at call with bank and other short-term liquid investments with original maturities of three months or less. ## **Critical accounting estimates and areas of judgment** In the view of the trustees in applying the accounting policies adopted, no judgements were required that have a significant effect on the amounts recognised in the financial statements nor do any estimates or assumptions made carry a significant risk of material adjustment in the next financial year. ## **Leases** Operating lease rentals are charged to the Statement of Financial Activities on a straight line basis over the period of the lease. ## **2 Donation and Legacies** |Donations
Legacies|**Unrestricted**
**Funds**
**Restricted**
**Funds**
**Total Funds**
**2024**
**Total Funds**
**2023**
**£**
**£**
**£**
**£**
198,996
216,302
415,298
324,502
37,500
-
37,500
269,173| |---|---| ||**236,496**
**216,302**
**452,798**
**593,675**| _____________________________________________________________________________ 17 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME** ## **Notes to the accounts for the year ended 30 September 2024** **_________________________________________________________________________________________________________** ## **3 Income from Charitable Activities** |Charitable activities - Fundraising|**Unrestricted**
**Funds**
**Restricted**
**Funds**
**Total Funds**
**2024**
**Total Funds**
**2023**
**£**
**£**
**£**
**£**
248,549
33,103
281,652
337,302| |---|---| ||**248,549**
**33,103**
**281,652**
**337,302**| ## **4 Fundraising Expenditure** |Direct Fundraising Expenses
Fundraising Costs
Fundraising Materials
Share of staff Cost (note 6.1)
Share of Support Costs (note 6.2)
**Total expenditure**|**Unrestricted**
**Funds**
**Restricted**
**Funds**
**Total Funds**
**2024**
**Total Funds**
**2023**
**£**
**£**
**£**
**£**
35,646
-
35,646
22,884
7,897
-
7,897
13,880
91,904
-
91,904
113,649
16,251
-
16,251
26,336| |---|---| ||**151,698**
**-**
**151,698**
**176,749**| ## **5 Total Charitable Expenditure** |**Total Charitable Expenditure**|| |---|---| |Direct Charitable Expenses
Event Costs
Website
Financial Assistance Members &
Partner group
Information Materials
Database and Membership
Magazine
Reach Ova resources
Film Resources and Photography
PR Costs
Raising Awareness Costs
Miscellaneous Costs
Share of staff Cost (note 6.1)
Share of Support Costs (note 6.2)
**Total expenditure**|**Unrestricted**
**Funds**
**Restricted**
**Funds**
**Total Funds**
**2024**
**Total Funds**
**2023**
**£**
**£**
**£**
**£**
2,417
24,797
27,214
15,093
6,884
3,427
10,311
11,663
18
3,528
3,546
6,096
120
7,807
7,927
6,928
8,030
2,967
10,997
8,715
22,398
24,821
47,219
22,523
3,098
3,098
7,039
1,045
-
1,045
6,775
502
502
8,250
1,952
1,246
3,198
1,750
689
2,647
3,336
966
409,197
168,131
577,328
516,943
72,357
35,942
108,299
109,650| ||**525,107**
**278,913**
**804,020**
**722,391**| _____________________________________________________________________________ 18 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME** ## **Notes to the accounts for the year ended 30 September 2024** **_________________________________________________________________________________________________________** |**6**|**Staff Costs(6.1)**|**Unrestricted**|**Restricted**|**Total Funds**|**Total Funds**| |---|---|---|---|---|---| |||**Funds**|**Funds**|**2024**|**2023**| |||**£**|**£**|**£**|**£**| ||Wages & Salaries|431,415|168,131|599,546|566,151| ||Social Security Costs|57,330|-|57,330|52,468| ||Pension Cost|12,356|-|12,356|11,973| |||**501,101**|**168,131**|**669,232**|**630,592**| ||||||| ||**Staff Cost allocated to:**||||| ||Fundraising costs|91,904|-|91,904|74,537| ||Charitable activities costs|409,197|168,131|577,328|556,055| |||**501,101**|**168,131**|**669,232**|**630,592**| ||||||| |||||**2024**|**2023**| ||Staff Numbers (average number of staff)|||17|16| No trustees received reimbursed expenses in the year (2023: nil) The number of employees whose employee benefits (excluding employers pension cost) exceeded £ 60,000 was: |||||2024|2023| |---|---|---|---|---|---| |£|60001|to £|70000|2|-| |£|70001|to £|80000|-|1| |£|80001|to £|90000|1|-| Trustees were not paid remuneration in either period. Key management personnel include the Trustees and the Chief Executive. The total employee benefits (including gross pay and employer national insurance contributions) of the charity's key management personnel were £88,793 (2023: £83,594). Pension contributions paid by the company to key management personnel totalled £1,321 (2023:£1,321). Excluding the trustees there was one key management personnel (2023: one) that received remuneration during the year. Under FRS 102, employee benefits include gross salary, employers national Insurance, employers pension contributions and benefits in kind. _____________________________________________________________________________ 19 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME** ## **Notes to the accounts for the year ended 30 September 2024** **_________________________________________________________________________________________________________** |**6**
**Support Costs (6.2)**
Rent
Printing and Stationary
Offce Cost
Professional fee
IT and computer Cost
Insurance
Depreciation
Staff training and support
Social media and advertising
Governance costs (Note 6.3)
**Support Cost allocated to:**
Fundraising costs
Charitable activities costs
**6**
**Governance Costs (6.3)**
Independent Examiner's fee
Accountancy fee
AGM and other expenses|**Unrestricted**
**Funds**
**Restricted**
**Funds**
**Total Funds**
**2024**
**Total Funds**
**2023**
**£**
**£**
**£**
**£**
13,028
8,659
21,687
19,290
2,977
480
3,457
3,948
11,834
3,427
15,261
17,683
10,568
-
10,568
10,184
14,876
8,148
23,024
26,363
2,453
-
2,453
2,220
1,468
-
1,468
1,836
10,184
11,181
21,365
23,548
16,800
4,047
20,847
28,049
4,420
-
4,420
2,865|**Unrestricted**
**Funds**
**Restricted**
**Funds**
**Total Funds**
**2024**
**Total Funds**
**2023**
**£**
**£**
**£**
**£**
13,028
8,659
21,687
19,290
2,977
480
3,457
3,948
11,834
3,427
15,261
17,683
10,568
-
10,568
10,184
14,876
8,148
23,024
26,363
2,453
-
2,453
2,220
1,468
-
1,468
1,836
10,184
11,181
21,365
23,548
16,800
4,047
20,847
28,049
4,420
-
4,420
2,865| |---|---|---| ||**88,608**
**35,942**
**124,550**
**135,986**|| ||16,251
-
16,251
19,468
72,357
35,942
108,299
116,518|| ||**88,608**
**35,942**
**124,550**
**135,986**|| |||2024
2023
£
£
2,282
694
1,616
1,616
522
555| |||4,420
2,865| _____________________________________________________________________________ 20 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Notes to the accounts for the year ended 30 September 2024** **_________________________________________________________________________________________________________** ## **7 TANGIBLE FIXED ASSETS** |**Cost**
At 1st Oct 2023
Additions
At 30 Sep 2024
**Depreciation**
At 1st Oct 2023
Provided during year
At 30 Sep 2024
**Net book value**
At 30 Sep 2024
At 1st Oct 2023
**8**
**DEBTORS**
Prepayments and accrued income
Other debtors
**9**
**CREDITORS: amounts falling due within one year**
Deferred Income
Trade creditors
Grant payable
Accruals
Other Creditors|**Computer**
**Equipment**
**Mascot**
**costume**
**Total 2024**
**£**
**£**
**£**
14,828
2,890
17,718
1,153
-
1,153|**Computer**
**Equipment**
**Mascot**
**costume**
**Total 2024**
**£**
**£**
**£**
14,828
2,890
17,718
1,153
-
1,153| |---|---|---| ||15,981
2,890
18,871|| ||10,794
2,087
12,881
1,042
426
1,468|| ||11,836
2,513
14,349|| |||| ||**4,145**
**377**
**4,522**|| |||| ||4,034
803
4,837|| |||**2024**
**2023**
**£**
**£**
11,179
11,179
-
-
**11,179**
**11,179**
**2024**
**2023**
**£**
**£**
83,509
-
25,945
24,379
7,427
7,427
3,800
5,960
2,835
247
**123,516**
**38,013**| _____________________________________________________________________________ 21 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME Notes to the accounts for the year ended 30 September 2024** **_________________________________________________________________________________________________________** **10 ANALYSIS OF FUNDS 2024** |**Restricted Funds**
Support services
Staying Connected
Choir
OVA to You
Education
Regional Support
Reach OVA
Patient's Perspective
Core costs
Sub-total Restricted funds
**Unrestricted Funds**
General Fund
Designated Funds -
- Research Fund
Sub-total Designated funds
**Total funds**|**Balance**
**30 Sep**
**2023**
**Income Expenditure**
**Funds**
**transfer**
**Balance 30**
**Sep 2024**
**£**
**£**
**£**
**£**
**£**
14,868
73,973
(88,381)
-
460
-
9,160
(4,500)
-
4,660
1,498
-
(1,498)
-
-
-
31,000
(22,949)
-
8,051
-
55
(55)
-
-
-
31,240
(15,240)
-
16,000
33,909
100,009
(106,949)
-
26,969
29,945
3,948
(33,893)
-
-
5,428
20
(5,448)
-
-| |---|---| ||85,648
249,405
(278,913)
-
56,140| ||576,618
495,436
(676,805)
-
395,249| ||36,765
-
-
36,765| ||36,765
-
-
-
36,765| ||| ||**699,031**
**744,841**
**(955,718)**
**-**
**488,154**| **Support services:** We received funding towards the direct costs of our support services for those affected by ovarian cancer. Thank you for the support we received from BEAT:Cancer. **Staying connected** : We received funding towards our programme of online support, information, and activities for people affected by ovarian cancer. Thank you for the support from Sport England. **Choir:** Funds were provided to enable Ovacome to continue the Ovacome choir. **Ova to You:** We received funding to enable Ovacome to run monthly support events across the UK. Thank you for the support from National Lottery Community Fund Awards For All programme, Medicash Foundation and Hemby Charitable Trust. **Education:** We received funding towards our education programme for medical students and healthcare professionals. **Regional support:** We received funding towards the continuation of our West Midlands Support services. Thank you for the support from The Eveson Trust. **Reach OVA** : We received funding towards our work to provide support and information to those who are less well represented within our membership and to those who experience additional health inequalities. These include but are not limited to: _____________________________________________________________________________ 22 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME** ## **Notes to the accounts for the year ended 30 September 2024** **_________________________________________________________________________________________________________** - Those who are LGBTQIA+. - Individuals and community groups that support people of colour and/or ethnic groups other than white. - Those over the age of 75 or under 45 at point of diagnosis. - Those who are experiencing financial hardship or who have a low income. - Those who are rurally isolated. - Those from Gypsy Roma Traveller Showmen and Boatmen communities. - Those who have a learning disability and/or are neurodivergent. This funding has been used as per the restrictions to provide specialist resources and targeted groups and campaigns. Thank you for the funding from Zurich Community Trust to support this work. **Patient perspective:** We received funding to support our patient perspective research. **Core costs:** We received funds towards our core costs. ## **ANALYSIS OF PRIOR YEAR FUNDS 2023** |**Restricted Funds**
Support services
Staying Connected
Choir
OVA to You
Information resources
Education
Regional Support
Reach OVA
Patient's Perspective
Core costs
Sub-total Restricted funds
**Unrestricted Funds**
General Fund
Designated Funds -
- Research Fund
Sub-total Designated funds
**Total funds**|**Balance**
**30 Sep**
**2022**
**Income Expenditure**
**Funds**
**transfer**
**Balance 30**
**Sep 2023**
**£**
**£**
**£**
**£**
-
100,824
(85,956)
-
14,868
-
3,802
(3,802)
-
-
2,342
3,500
(4,344)
-
1,498
4,517
-
(8,075)
3,558
-
-
-
-
-
-
15,276
-
(13,268)
(2,008)
-
12,642
11,406
(24,048)
-
-
42,142
48,333
(55,991)
(575)
33,909
-
31,602
(1,657)
-
29,945
-
6,888
(1,460)
-
5,428| |---|---| ||76,919
206,355
(198,601)
975
85,648| ||546,106
732,026
(700,539)
(975)
576,618| ||36,765
-
-
-
36,765| ||36,765
-
-
-
36,765| ||| ||**659,790**
**938,381**
**(899,140)**
**-**
**699,031**| _____________________________________________________________________________ 23 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c **OVACOME** ## **Notes to the accounts for the year ended 30 September 2024** **_________________________________________________________________________________________________________** ## **11 ANALYSIS OF NET ASSETS BY FUNDS** |Fixed assets
Current assets
Current liabilities
Net assets 2024
Fixed assets
Current assets
Current liabilities
Net assets 2023|**Unrestricted**
**Fund**
**Restricted**
**Fund**
**Total Fund**
**2024**
**£**
**£**
**£**
4,522
-
4,522
551,008
56,140
607,148
(123,516)
-
(123,516)| |---|---| ||432,014
56,140
**488,154**| ||**Unrestricted**
**Fund**
**Restricted**
**Fund**
**Total Fund**
**2023**
**£**
**£**
**£**
4,837
-
4,837
646,559
85,648
732,207
(38,013)
-
(38,013)| ||613,383
85,648
**699,031**| ## **12 OPERATING LEASE COMMITMENTS** At 30 September 2024 the charity had future minimum commitments in respect of non-cancellable operating leases as follows |**Rental expenses**
Not later than 1 year
Between 1 and 5 years
Total|**2024**
**2023**
**£**
**£**
9,852
16,855
-
2,000| |---|---| ||9,852
18,855| ## **13 DONATIONS FROM RELATED PARTIES** The charity received donations from related parties £2,096 (2023: £1,206). _____________________________________________________________________________ 24 Doc ID: 3a47beaaac42e54d48c105b7b11632ade84a284c